These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 28523551)

  • 1. Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis.
    Jimenez-Pacheco A; Franco JM; Lopez S; Gomez-Zumaquero JM; Magdalena Leal-Lasarte M; Caballero-Hernandez DE; Cejudo-Guillén M; Pozo D
    Adv Exp Med Biol; 2017; 978():255-275. PubMed ID: 28523551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
    Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
    Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targeting of epigenetic components in amyotrophic lateral sclerosis (ALS).
    Lee J; Ryu H; Keum G; Yoon YJ; Kowall NW; Ryu H
    Curr Med Chem; 2014; 21(31):3576-82. PubMed ID: 25005187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALS and FTD: an epigenetic perspective.
    Belzil VV; Katzman RB; Petrucelli L
    Acta Neuropathol; 2016 Oct; 132(4):487-502. PubMed ID: 27282474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.
    Paez-Colasante X; Figueroa-Romero C; Sakowski SA; Goutman SA; Feldman EL
    Nat Rev Neurol; 2015 May; 11(5):266-79. PubMed ID: 25896087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease.
    Bennett SA; Tanaz R; Cobos SN; Torrente MP
    Transl Res; 2019 Feb; 204():19-30. PubMed ID: 30391475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics of Huntington's Disease.
    Bassi S; Tripathi T; Monziani A; Di Leva F; Biagioli M
    Adv Exp Med Biol; 2017; 978():277-299. PubMed ID: 28523552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of histone deacetylase inhibition and arimoclomol on heat shock protein expression and disease biomarkers in primary culture models of familial ALS.
    Fernández Comaduran M; Minotti S; Jacob-Tomas S; Rizwan J; Larochelle N; Robitaille R; Sephton CF; Vera M; Nalbantoglu JN; Durham HD
    Cell Stress Chaperones; 2024 Jun; 29(3):359-380. PubMed ID: 38570009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Changes Associated with the Expression of Amyotrophic Lateral Sclerosis (ALS) Causing Genes.
    Masala A; Sanna S; Esposito S; Rassu M; Galioto M; Zinellu A; Carru C; Carrì MT; Iaccarino C; Crosio C
    Neuroscience; 2018 Oct; 390():1-11. PubMed ID: 30134203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms.
    Martin LJ; Wong M
    Neurotherapeutics; 2013 Oct; 10(4):722-33. PubMed ID: 23900692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
    Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
    Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IN VITRO AND IN VIVO MODELS OF AMYOTROPHIC LATERAL SCLEROSIS: AN UPDATED OVERVIEW.
    Gois AM; Mendonça DMF; Freire MAM; Santos JR
    Brain Res Bull; 2020 Jun; 159():32-43. PubMed ID: 32247802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulations of Expression of Genes of the Ubiquitin/SUMO Pathways in an In Vitro Model of Amyotrophic Lateral Sclerosis Combining Oxidative Stress and SOD1 Gene Mutation.
    Dangoumau A; Marouillat S; Coelho R; Wurmser F; Brulard C; Haouari S; Laumonnier F; Corcia P; Andres CR; Blasco H; Vourc'h P
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
    Hayashi Y; Homma K; Ichijo H
    Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylation and motor neuron degeneration.
    Schmalbach S; Petri S
    CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):279-84. PubMed ID: 20406183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.
    Rinchetti P; Rizzuti M; Faravelli I; Corti S
    Mol Neurobiol; 2018 Mar; 55(3):2617-2630. PubMed ID: 28421535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model.
    Rossaert E; Pollari E; Jaspers T; Van Helleputte L; Jarpe M; Van Damme P; De Bock K; Moisse M; Van Den Bosch L
    Acta Neuropathol Commun; 2019 Jul; 7(1):107. PubMed ID: 31277703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis.
    Riancho J; Gonzalo I; Ruiz-Soto M; Berciano J
    Neurologia (Engl Ed); 2019; 34(1):27-37. PubMed ID: 26853842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichostatin A Relieves Growth Suppression and Restores Histone Acetylation at Specific Sites in a FUS ALS/FTD Yeast Model.
    Bennett SA; Cobos SN; Mirzakandova M; Fallah M; Son E; Angelakakis G; Rana N; Hugais M; Torrente MP
    Biochemistry; 2021 Dec; 60(48):3671-3675. PubMed ID: 34788013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
    Harrison IF; Dexter DT
    Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.